Guggenheim Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,291
| Closed | -$3.22M | – | 2049 |
|
|
2022
Q3 | $3.22M | Sell |
21,291
-5,754
| -21% | -$870K | 0.03% | 662 |
|
|
2022
Q2 | $3.94M | Buy |
27,045
+2,826
| +12% | +$412K | 0.03% | 641 |
|
|
2022
Q1 | $2.87M | Sell |
24,219
-179
| -0.7% | -$21.2K | 0.02% | 867 |
|
|
2021
Q4 | $3.36M | Buy |
24,398
+5,477
| +29% | +$755K | 0.02% | 835 |
|
|
2021
Q3 | $2.63M | Sell |
18,921
-5,131
| -21% | -$713K | 0.02% | 914 |
|
|
2021
Q2 | $2.34M | Sell |
24,052
-4,043
| -14% | -$393K | 0.01% | 1009 |
|
|
2021
Q1 | $1.92M | Buy |
28,095
+2,312
| +9% | +$158K | 0.01% | 1055 |
|
|
2020
Q4 | $2.21M | Buy |
+25,783
| New | +$2.21M | 0.01% | 926 |
|